Taiwan · Delayed Price · Currency is TWD Excelsior Biopharma Company Description
Excelsior Biopharma Inc. develops and sells pharmaceutical products in Taiwan, China, and internationally.
It offers general pharmaceuticals; orphan drugs; antidotes; rapid test kits and reagent; consumer products under the Repavar, Om3gafort, Oral7, and Excelsior Probiotics brand names; and over the counter drugs under the Norit, Puresenna, and Tazac brand names.
The company also provides specialty medicine and public health products. In addition, it is involved in importing and exporting of active pharmaceutical ingredients, food, and cosmeceuticals; development of cosmetics; research, importing and exporting of technologies; and pharmaceutical technologies transfer.
The company was formerly known as Excelsior Enterprise Co., Ltd. and changed its name to Excelsior Biopharma Inc. in June 2003.
Excelsior Biopharma Inc. was founded in 1986 and is headquartered in Taipei, Taiwan.
| Country | Taiwan |
| Founded | 1986 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Joseph Chen |
Contact Details
Address: No. 508, Zhongxiao E. Rd. Taipei, 11561 Taiwan | |
| Phone | 886 2 2655 7568 |
| Website | excelsiorgroup.com.tw |
Stock Details
| Ticker Symbol | 6496 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006496003 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Joseph Chen | Founder, Chairman, President and GM |
| Chia-Ling Chen | Representative Director, New Business Development Manager and Associate Manger to the President Office |
| Po-Tang Cheng | Senior Director General of Taiwan Business Division |
| Ya-Wen Huang | Director General of Consumer Product Business Division |
| Pi-Ching Wu | Director General of Specialty Medicine Business Division |
| Ming-Tse Chen | Financial Manager and Chief Accountant |